CLINICAL_TRIALS
trial_result
· 2016-01-14
Clinical Trial Update: Afatinib in Subjects With Kidney Dysfunction [Phase 1]
Summary
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of afatinib in adults with kidney dysfunction; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2016-01-14